Abstract
Protection Against Ischemia-Induced Neuronal Damage by the α2-Adrenoceptor Antagonist Idazoxan: Influence of Time of Administration and Possible Mechanisms of Action
Ingvar Gustafson, Eva Westerberg, Tadeusz Wieloch
[Originally published in Journal of Cerebral Blood Flow and Metabolism 1990;10(6):885–894]
In last paragraph, fourth line, on page 891 of the above, the word “noradrenergic” was erroneously used in the place of “non-adrenergic.” The correct wording is as follows: “Idazoxan has affinity to non-adrenergic binding sites in the brain.” The publisher regrets this error.